Shaping the future of our DKMS Group
The Foundation Board and global executive team are shaping the future of the DKMS group.
They are advised by our Medical Council. The Foundation Board and global executive team are responsible for setting the strategic direction of our DKMS group at an international level. As consultants, they also provide advice and support to our management teams at the entities in the development of local strategies.
Chief Executive Officer: Dr. Elke Neujahr
In 2018, Elke Neujahr rejoined a cause that had long been close to her heart by becoming Global CEO of the DKMS Group, as well as Executive Vice-Chairwoman of the Board of Directors in the US and Chairwoman of the board in Poland, United Kingdom and South Africa. With a doctorate in communication sciences, Elke served national and international executives as an expert in all questions of corporate reputation, crisis and change management. Initially holding a variety of positions in the industry, Elke ultimately switched to the consulting side of the corporate communications business. She has been Partner and CEO of a leading European PR Consultancy , before she successfully ran her own company for 15 years. With her 40 years of expertise in general management she drives the development of the DKMS Group.
As the Global CEO, Elke oversees all DKMS operations and the organization’s continued international expansion.
“Every year, tens of thousands of donor searches are initiated across the globe. At DKMS, we are working to ensure that every patient in need finds a matching donor. Our mission is driven by the countless employees, for whom this is a matter close to the heart, and the millions of compassionate individuals across the world who we are proud to call our donors. We go out of our way to increase awareness and encourage people internationally to register as a blood stem cell donor. Aware of the need for a multifaceted approach, we will continue to extend our mission and are currently investing in providing access to transplantation. The only effective way to address blood cancer and other life-threatening blood diseases is with a macro perspective that ensures no patient is left behind, regardless of their geographic location or socio-economic status.”
Chief Financial Officer: Sirko Geist
Sirko Geist has been Managing Director and the Chief Financial Officer of DKMS since 2013. He oversees finance and accounting as well as the administration and management of the DKMS locations. His responsibilities also include process and quality management and legal services. On an international level he is active in various roles on the boards of the local DKMS entities.
Sirko studied law at the Technical University of Dresden and graduated with the first state examination. He successfully completed his legal clerkship in the Chemnitz district of the regional court with the second state examination. He also holds a Master of Business Administration from the Danube University Krems.
After numerous years working for a leading auditing company, he worked in management positions within the textile industry. At the end of 2009, he started working as the Commercial Manager of the DKMS Life Science Lab and since then he has been working in different leading positions in the DKMS Group.
Chief Medical Officer: Dr. Alexander Schmidt
Dr. Alexander Schmidt has been Managing Director and the Chief Medical Officer of DKMS since 2013. He is responsible for all areas that provide professional information and advice as well as coordination and support for donors before, during and after a donation, thus ensuring safe bone marrow and peripheral blood stem cell donations.
In addition, Alexander oversees the ongoing relationship management with transplant centres, search units and registries and the medical advice for all international DKMS entities. He and his teams are also responsible for various quality programs and scientific projects.
Alexander holds a doctorate in mathematics and medicine. After working as an intern at Heidelberg University Hospital, he worked as a management consultant with a focus on health care issues. He has been working for DKMS since 2002 in various management positions. He is also the Chief Executive Officer of the DKMS Life Science Lab and the DKMS Stem Cell Bank and Chief Scientific Officer of the DKMS Registry.
